Impact of multimodal therapy on the survival of patients with newly diagnosed uterine carcinosarcoma.

MLA

Machida, H., et al. “Impact of Multimodal Therapy on the Survival of Patients with Newly Diagnosed Uterine Carcinosarcoma.” European Journal of Gynaecological Oncology, vol. 34, no. 4, July 2013, pp. 291–95. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=181705942&authtype=sso&custid=ns315887.

APA

Machida, H., Takahashi, K., Nomura, H., Matoda, M., Omatsu, K., Kato, K., Umayahara, K., & Takeshima, N. (2013). Impact of multimodal therapy on the survival of patients with newly diagnosed uterine carcinosarcoma. European Journal of Gynaecological Oncology, 34(4), 291–295.

Chicago

Machida, H., K. Takahashi, H. Nomura, M. Matoda, K. Omatsu, K. Kato, K. Umayahara, and N. Takeshima. 2013. “Impact of Multimodal Therapy on the Survival of Patients with Newly Diagnosed Uterine Carcinosarcoma.” European Journal of Gynaecological Oncology 34 (4): 291–95. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=181705942&authtype=sso&custid=ns315887.